Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Oncternal Therapeutics, Inc.Listing unverified | Buy | n/a (No price was disclosed in the filing) | conv 30 | SEC | |
Oncternal Therapeutics, Inc.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Oncternal Therapeutics, Inc.Listing unverified | Buy | $6.2M | conv 47First in 12mo | SEC | |
Oncternal Therapeutics, Inc.Listing unverified | Buy | n/a (No price was disclosed in the filing) | conv 66First in 12mo | SEC | |
Oncternal Therapeutics, Inc.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC |